A detailed history of Cwa Asset Management Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 55,651 shares of ABBV stock, worth $9.77 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
55,651
Previous 42,243 31.74%
Holding current value
$9.77 Million
Previous $7.69 Million 42.86%
% of portfolio
0.59%
Previous 0.47%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$163.84 - $199.33 $2.2 Million - $2.67 Million
13,408 Added 31.74%
55,651 $11 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $404,024 - $460,348
2,528 Added 6.37%
42,243 $7.69 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $1.76 Million - $1.98 Million
12,794 Added 47.52%
39,715 $6.15 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $105,803 - $122,482
792 Added 3.03%
26,921 $4.01 Million
Q2 2023

Jul 27, 2023

BUY
$132.51 - $164.9 $148,676 - $185,017
1,122 Added 4.49%
26,129 $3.52 Million
Q1 2023

Apr 17, 2023

BUY
$144.61 - $166.54 $133,475 - $153,716
923 Added 3.83%
25,007 $3.99 Million
Q4 2022

Jan 09, 2023

BUY
$138.31 - $165.87 $71,506 - $85,754
517 Added 2.19%
24,084 $0
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $17,178 - $19,703
-128 Reduced 0.54%
23,567 $3.16 Million
Q2 2022

Jul 21, 2022

SELL
$137.62 - $174.96 $4,954 - $6,298
-36 Reduced 0.15%
23,695 $3.63 Million
Q1 2022

Apr 21, 2022

SELL
$131.98 - $163.75 $105,188 - $130,508
-797 Reduced 3.25%
23,731 $3.85 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $104,207 - $131,852
970 Added 4.12%
24,528 $3.32 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $153,535 - $174,285
1,443 Added 6.52%
23,558 $2.54 Million
Q2 2021

Aug 03, 2021

SELL
$105.21 - $117.21 $36,507 - $40,671
-347 Reduced 1.54%
22,115 $2.53 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $31,815 - $35,024
311 Added 1.4%
22,462 $2.43 Million
Q4 2020

Feb 23, 2021

BUY
$80.49 - $108.67 $54,733 - $73,895
680 Added 3.17%
22,151 $2.37 Million
Q4 2020

Feb 09, 2021

SELL
$80.49 - $108.67 $127,657 - $172,350
-1,586 Reduced 6.88%
21,471 $2.3 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $963,051 - $1.13 Million
11,210 Added 94.62%
23,057 $2.02 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $937,521 - $1.25 Million
-12,778 Reduced 51.89%
11,847 $1.16 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $997,234 - $1.51 Million
15,461 Added 168.71%
24,625 $1.88 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $655,012 - $819,560
-9,081 Reduced 49.77%
9,164 $811,000
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $175,714 - $211,258
-2,790 Reduced 13.26%
18,245 $1.38 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $132,188 - $168,967
2,012 Added 10.58%
21,035 $1.53 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $118,024 - $138,908
1,530 Added 8.75%
19,023 $1.53 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $27,325 - $33,699
351 Added 2.05%
17,493 $1.61 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $314,474 - $349,597
-3,537 Reduced 17.1%
17,142 $1.62 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $28,460 - $33,674
317 Added 1.56%
20,679 $1.92 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $18,678 - $25,011
203 Added 1.01%
20,362 $1.93 Million
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $11,642 - $12,767
130 Added 0.65%
20,159 $1.95 Million
Q3 2017

Nov 13, 2017

SELL
$69.85 - $89.22 $3,492 - $4,461
-50 Reduced 0.25%
20,029 $1.78 Million
Q2 2017

Aug 10, 2017

BUY
N/A
20,079
20,079 $1.46 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cwa Asset Management Group, LLC Portfolio

Follow Cwa Asset Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwa Asset Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwa Asset Management Group, LLC with notifications on news.